Emerging Biomarkers and Therapeutic Pipelines for Chronic Spontaneous Urticaria

Gustavo Deza, Peter A. Ricketti, Ana M. Giménez-Arnau, Thomas B. Casale

Research output: Contribution to journalReview articleResearchpeer-review

23 Citations (Scopus)


© 2018 American Academy of Allergy, Asthma & Immunology Chronic spontaneous urticaria (CSU) is defined as the appearance of evanescent wheals, angioedema, or both, for at least 6 weeks. CSU is associated with intense pruritus and poor quality of life, with higher odds of reporting depression, anxiety, and sleep difficulty. As of yet, the assessment of the activity and course of the disease along with the response to several treatments in CSU are based purely on the patient's medical history and the use of the patient-reported outcomes. Recently, several reports have suggested that certain parameters could be considered as potential disease-related biomarkers. Moreover, with the advent of such biomarkers, newer biologic agents are coming forth to revolutionize the management of potential refractory diseases such as CSU. The purpose of this article is to review the most promising biomarkers related to important aspects of CSU, such as the disease activity, the therapeutic response, and the natural history of the disease, and discuss the mechanisms of action and therapeutic effectiveness of the latest agents available or currently under investigation for the management of antihistamine-refractory CSU. The knowledge of these features could have an important impact on the management and follow-up of patients with CSU.
Original languageEnglish
Pages (from-to)1108-1117
JournalJournal of Allergy and Clinical Immunology: In Practice
Issue number4
Publication statusPublished - 1 Jul 2018


  • Biologics
  • Biomarkers
  • CRP
  • D-dimer
  • F1+2
  • IL-1 antagonists
  • IL-6
  • Intravenous immunoglobulin
  • Ligelizumab
  • MPV
  • Omalizumab
  • Quilizumab
  • Rituximab
  • TNF-α inhibitors
  • Urticaria


Dive into the research topics of 'Emerging Biomarkers and Therapeutic Pipelines for Chronic Spontaneous Urticaria'. Together they form a unique fingerprint.

Cite this